It isn't realistic. Was 3 of 4 of these events
Post# of 30028
Posted On: 01/18/2015 12:09:21 AM
Re: Deputy_123 #15562
Quote:
It isn't realistic.
Was 3 of 4 of these events in the last two months realistic for a small "microcap" company? You just never know what's going to happen next.
Jan. 15, 2015 - Amarantus Announces Exclusive Option Agreement With Georgetown University to License Patent Rights for Blood Based Biomarkers for Alzheimer's Disease
Jan. 12, 2015 - Amarantus Announces Acquisition of Specialized Neuro-Diagnostics Company, DioGenix
Dec. 23, 2014 - Amarantus Receives Orphan Drug Designation for MANF From U.S. Food and Drug Administration for Treatment of Retinitis Pigmentosa
Nov. 17, 2014 - Amarantus Enters Into Exclusive Option Agreement to Acquire Engineered Skin Substitute for the Treatment of Severe Burns From Lonza
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼